These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

692 related articles for article (PubMed ID: 22064480)

  • 1. Selective signaling by Akt1 controls osteoblast differentiation and osteoblast-mediated osteoclast development.
    Mukherjee A; Rotwein P
    Mol Cell Biol; 2012 Jan; 32(2):490-500. PubMed ID: 22064480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective signaling by Akt2 promotes bone morphogenetic protein 2-mediated osteoblast differentiation.
    Mukherjee A; Wilson EM; Rotwein P
    Mol Cell Biol; 2010 Feb; 30(4):1018-27. PubMed ID: 19995912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.
    Udagawa N; Takahashi N; Jimi E; Matsuzaki K; Tsurukai T; Itoh K; Nakagawa N; Yasuda H; Goto M; Tsuda E; Higashio K; Gillespie MT; Martin TJ; Suda T
    Bone; 1999 Nov; 25(5):517-23. PubMed ID: 10574571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogens antagonize RUNX2-mediated osteoblast-driven osteoclastogenesis through regulating RANKL membrane association.
    Martin A; Xiong J; Koromila T; Ji JS; Chang S; Song YS; Miller JL; Han CY; Kostenuik P; Krum SA; Chimge NO; Gabet Y; Frenkel B
    Bone; 2015 Jun; 75():96-104. PubMed ID: 25701138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
    Cai X; Xing J; Long CL; Peng Q; Humphrey MB
    J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Streptococcus gordonii induces bone resorption by increasing osteoclast differentiation and reducing osteoblast differentiation.
    Park OJ; Kim J; Kim HY; Kwon Y; Yun CH; Han SH
    Microb Pathog; 2019 Jan; 126():218-223. PubMed ID: 30414445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emodin regulates bone remodeling by inhibiting osteoclastogenesis and stimulating osteoblast formation.
    Kim JY; Cheon YH; Kwak SC; Baek JM; Yoon KH; Lee MS; Oh J
    J Bone Miner Res; 2014 Jul; 29(7):1541-53. PubMed ID: 25832436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substance P stimulates bone marrow stromal cell osteogenic activity, osteoclast differentiation, and resorption activity in vitro.
    Wang L; Zhao R; Shi X; Wei T; Halloran BP; Clark DJ; Jacobs CR; Kingery WS
    Bone; 2009 Aug; 45(2):309-20. PubMed ID: 19379851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoclast differentiation by RANKL and OPG signaling pathways.
    Udagawa N; Koide M; Nakamura M; Nakamichi Y; Yamashita T; Uehara S; Kobayashi Y; Furuya Y; Yasuda H; Fukuda C; Tsuda E
    J Bone Miner Metab; 2021 Jan; 39(1):19-26. PubMed ID: 33079279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Akt1 in osteoblasts and osteoclasts controls bone remodeling.
    Kawamura N; Kugimiya F; Oshima Y; Ohba S; Ikeda T; Saito T; Shinoda Y; Kawasaki Y; Ogata N; Hoshi K; Akiyama T; Chen WS; Hay N; Tobe K; Kadowaki T; Azuma Y; Tanaka S; Nakamura K; Chung UI; Kawaguchi H
    PLoS One; 2007 Oct; 2(10):e1058. PubMed ID: 17957242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PDK1 is important lipid kinase for RANKL-induced osteoclast formation and function via the regulation of the Akt-GSK3β-NFATc1 signaling cascade.
    Xiao D; Zhou Q; Gao Y; Cao B; Zhang Q; Zeng G; Zong S
    J Cell Biochem; 2020 Nov; 121(11):4542-4557. PubMed ID: 32048762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
    Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
    Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrolactin F inhibits RANKL-mediated osteoclastogenesis by suppressing Akt, MAPK and NFATc1 pathways and promotes osteoblastogenesis through a BMP-2/smad/Akt/Runx2 signaling pathway.
    Li L; Sapkota M; Gao M; Choi H; Soh Y
    Eur J Pharmacol; 2017 Nov; 815():202-209. PubMed ID: 28919027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear Factor-Kappa B Regulation of Osteoclastogenesis and Osteoblastogenesis.
    Boyce BF; Li J; Yao Z; Xing L
    Endocrinol Metab (Seoul); 2023 Oct; 38(5):504-521. PubMed ID: 37749800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acvr1 deletion in osteoblasts impaired mandibular bone mass through compromised osteoblast differentiation and enhanced sRANKL-induced osteoclastogenesis.
    Hu Y; Hao X; Liu C; Ren C; Wang S; Yan G; Meng Y; Mishina Y; Shi C; Sun H
    J Cell Physiol; 2021 Jun; 236(6):4580-4591. PubMed ID: 33251612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
    Häusler KD; Horwood NJ; Chuman Y; Fisher JL; Ellis J; Martin TJ; Rubin JS; Gillespie MT
    J Bone Miner Res; 2004 Nov; 19(11):1873-81. PubMed ID: 15476588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic Dinucleotides Inhibit Osteoclast Differentiation Through STING-Mediated Interferon-β Signaling.
    Kwon Y; Park OJ; Kim J; Cho JH; Yun CH; Han SH
    J Bone Miner Res; 2019 Jul; 34(7):1366-1375. PubMed ID: 30779854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transglutaminases factor XIII-A and TG2 regulate resorption, adipogenesis and plasma fibronectin homeostasis in bone and bone marrow.
    Mousa A; Cui C; Song A; Myneni VD; Sun H; Li JJ; Murshed M; Melino G; Kaartinen MT
    Cell Death Differ; 2017 May; 24(5):844-854. PubMed ID: 28387755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-Abl-dependent molecular circuitry involving Smad5 and phosphatidylinositol 3-kinase regulates bone morphogenetic protein-2-induced osteogenesis.
    Ghosh-Choudhury N; Mandal CC; Das F; Ganapathy S; Ahuja S; Ghosh Choudhury G
    J Biol Chem; 2013 Aug; 288(34):24503-17. PubMed ID: 23821550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.